Stay in Touch

Truvian in the news.

Founders’ Story: Truvian Sciences

MedCityNews- August 4, 2020

In a Q&A, Truvian Sciences CEO Jeff Hawkins and Dena Marrinucci, founder and SVP Corporate Development and Business Operations talk about their point-of care blood testing technology.... Read more

...

FDA approves COVID-19 antibody test made by San Diego company

ABC 10 News San Diego- July 29, 2020

The FDA Wednesday gave emergency approval to a San Diego company's test for COVID-19 antibodies. Easy Check, from Truvian Sciences, can test for COVID-19 antibodies in under 10 minutes.... Watch

...

FDA Grants Emergency Use Authorizations for Access Bio, Truvian Sciences Coronavirus Antibody Tests

360Dx- July 29, 2020

The US Food and Drug Administration has granted separate Emergency Use Authorizations (EUAs) for SARS-CoV-2 antibody tests developed by Access Bio and Truvian Sciences.... Read more

...

Truvian Sciences Receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG™ Test

BioSpace- July 29, 2020

Truvian Sciences today announced that the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the company's Easy Check COVID-19 IgM/IgGTM antibody test. Truvian's Easy Check test is being produced at mass scale at a US based...... Read more

...

Truvian Tweets

@truviansciences

- 3 days ago

Join us tomorrow for an expert discussion on the value, utility and limitations of #Covid19 #AntibodyTesting featuring Dr. Jerry Yeo and Dr. Stephen Rawlings. Webinar starts tomorrow @ 1 pm ET. Register here: https://t.co/EPdIXgKxsk #InfectiousDisease #SARSCoV2 #CovidTesting https://t.co/bbKvcn7Pnz
h J R
@truviansciences

- 8 days ago

@ReneeTruhealth: “The thing is, the immune system is very complicated …” Somehow @edyong209 manages to explain the immune system in a way that's easier to understand! #COVID19 #Immunity https://t.co/wc28lVon1z
h J R
@truviansciences

- 8 days ago

@kcatkinsonTru: Learn more about the utility of lateral flow antibody tests. Sign up now for the August 12th webinar powered by @360DxNews and sponsored by @TruvianSciences featuring leading expert KT Jerry Yeo, PhD, DABCC, FACB from the University of Chicago. https://t.co/qyTDid2O8D
h J R
@truviansciences

- 8 days ago

@DeviceTalks: @TruvianSciences announced that it received FDA emergency use authorization (EUA) for its Easy Check #COVID19 IgM/IgG antibody test.https://t.co/i119cUC3vr
h J R
@truviansciences

- 8 days ago

Start-up enters COVID-19 testing game with low-cost kit that delivers results in 10 minutes https://t.co/OXt6ha0ee3
h J R

The Latest from Truvian

Truvian Sciences Receives FDA Emergency Use Authorization for Easy Check COVID-19 IgM/IgG™ Test

July 29, 2020

Rigorously and independently tested and validated, Easy Check exceeds current testing requirements for the detection of IgM/IgG antibodies to SARS-CoV-2 SAN DIEGO, July 29, 2020 — Truvian Sciences (“Truvian”), a healthcare company at the intersection of diagnostics and consumer technology, today... Read more

...

Truvian Sciences Expands Focus to Address Surge in Demand for Antibody Tests; Introduces Easy Check COVID-19 IgM/IgG Test

June 17, 2020

Truvian’s Easy Check will create higher standards of performance, speed, and scalability for the rapid detection of IgM/IgG antibodies to SARS-CoV-2 SAN DIEGO, June 17, 2020 — Truvian Sciences (“Truvian”), a healthcare company at the intersection of diagnostics and consumer technology,... Read more

...

Truvian Sciences Names Jean-Pierre Millon to its Board of Directors

April 21, 2020

Decorated Healthcare Executive and Current CVS Health Director Brings Deep Expertise to Burgeoning Blood Testing Company SAN DIEGO, April 21, 2020 — Truvian Sciences (“Truvian”),a healthcare company at the intersection of diagnostics and consumer technology, today announced that healthcare executive Jean-Pierre... Read more

...

Truvian Sciences Debuts New Headquarters in San Diego

December 19, 2019

Company Moves to New World-Class Laboratory and Office Space on Heels of $27.1 Million Series B Financing SAN DIEGO, Dec. 19, 2019 — Truvian Sciences (“Truvian”) will celebrate today the official debut of the company’s new 36,000 square-foot headquarters in... Read more

...

Truvian Sciences Accelerates Plans With $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests

November 20, 2019

Company Aims to Make Routine Health Testing Convenient, Affordable and Actionable Led by Former Illumina Executive Jeff Hawkins as Chief Executive Officer Company Expands Leadership Team with the Addition of Katherine Atkinson as Chief Commercial Officer and Paul Meister to... Read more

...